Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Myoscience is a medical technology company focused on developing and commercializing advanced cryoneurolysis solutions for non-opioid pain management. The company's flagship product, the iovera° system, is a handheld device that delivers extreme cold to peripheral nerves, blocking pain signals without damaging the nerve structure. This treatment provides immediate and long-lasting pain relief for patients suffering from chronic conditions like osteoarthritis or recovering from orthopedic surgeries. The technology utilizes the body's natural response to cold to provide a targeted, drug-free alternative to traditional analgesics. In 2019, Myoscience was acquired by Pacira BioSciences to complement their existing non-opioid pain management portfolio.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on myoscience.